tiprankstipranks

LFSC Price & Analysis

Compare

LFSC ETF Chart & Stats

ETF Overview

F/M Emerald Life Sciences Innovation ETF

The F/M Emerald Life Sciences Innovation ETF (ticker: LFSC) is a dynamic investment vehicle tailored for those seeking exposure to cutting-edge advancements within the health care sector. This ETF is specifically concentrated on the Pharma, Biotech & Life Sciences niche, offering investors a unique opportunity to capitalize on the rapid innovation and growth potential in these fields. LFSC targets companies at the forefront of pharmaceutical development, biotechnology breakthroughs, and life sciences research, encompassing a broad spectrum of pioneering firms that are driving transformative changes in health care. With a focus on delivering strategic access to this vital segment, the F/M Emerald Life Sciences Innovation ETF is ideal for investors looking to diversify their portfolio with high-impact, future-focused investments that have the potential to redefine the health care landscape.
Asset Class
Equity
Region
North America
Issuer
F/m
Index Tracked
No Underlying Index
Ticker Symbol
LFSC

F/M Emerald Life Sciences Innovation ETF (LFSC) Fund Flow Chart

F/M Emerald Life Sciences Innovation ETF (LFSC) 1 year Net Flows: $3M

LFSC ETF FAQ

What was LFSC’s price range in the past 12 months?
LFSC lowest ETF price was $23.35 and its highest was $27.76 in the past 12 months.
    What is the AUM of LFSC?
    As of Jan 31, 2025 The AUM of LFSC is 56.25M.
      Is LFSC overvalued?
      According to Wall Street analysts LFSC’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does LFSC pay dividends?
        LFSC does not currently pay dividends.
        How many shares outstanding does LFSC have?
        Currently, no data Available
        Which hedge fund is a major shareholder of LFSC?
        Currently, no hedge funds are holding shares in LFSC

        LFSC ETF Smart Score

        For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

        Top 10 Holdings

        Name
        Weight %
        Radnet
        6.70%
        Blueprint Medicines Corp.
        6.47%
        Bridgebio Pharma
        6.34%
        Akero Therapeutics
        6.24%
        Insmed
        5.91%
        LivaNova PLC
        5.32%
        Travere Therapeutics, Inc.
        5.29%
        Merit Medical
        5.20%
        Wave Life Sciences Pte. Ltd
        4.94%
        Ultragenyx Pharmaceutical, Inc.
        4.32%
        Total56.74%
        See All Holdings
        Popular ETFs
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis